News & Press Releases

This is the fourth and final installment of a series from Mintz’s Health Law team recapping key government policies, regulations and enforcement actions from 2016 and discussing their potential impacts on 2017.

This article, published in Medical Marketing & Media, addresses the FDA’s new approach to regulating drugmakers’ advertising and promotion. Mintz FDA team members Bethany Hills and Joanne Hawana offer insight. 

This article highlights Stephen Akerley’s arrival at Mintz as a member in the firm’s San Francisco office. Steve’s work involves intellectual property law and patent litigation practices, among others, and has applications in technology and manufacturing fields. 

This is the third installment of a four-part series recapping key government policies, regulations and enforcement actions from 2016 and discussing their potential impacts on 2017.

In this Law360 feature article, Joanne Hawana and Dan Herling discuss the release of data regarding adverse events received by the FDA’s Center for Food Safety and Applied Nutrition, whether the timing of the release matters, and what greater AER transparency means for litigations risks.

This Law360 article discusses contentious updates to the EB-5 visa program, which gives green cards to foreign residents who invest heavily in U.S. businesses.